Harvard Bioscience Inc. (HBIO) PT Raised to $7 at Benchmark, 'Q1 Beat & Raise; Outlook Improving; Raising Price Target'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Harvard Bioscience, Inc. (NASDAQ: HBIO) | Delayed: 8.23 -0.11 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.34 | 52 Week High | $3.90 | |||
| Open | $8.13 | 52 Week Low | $2.25 | |||
| Day High | $8.40 | P/E | N/A | |||
| Day Low | $8.10 | EPS | $-0.03 | |||
| Volume | 26,991 | |||||
